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Identification of target antigens in immune-mediated diseases provides an 
array of benefits for diagnosis, prediction of prognosis and responses to ther-
apy, and understanding disease pathogenesis. Several autoimmune blistering 
diseases, such as pemphigus vulgaris, serve as excellent models for which tar-
get antigen identification has been of significant benefit (Pan et al., 2011). The 
target antigens in Behçet’s disease (BD), however, have long eluded research-
ers. For BD, possible candidate antigens include vascular proteins, because 
the central histopathologic finding in BD is a vasculitis, and environmental 
factors such as infectious agents, which may cause cross-reactivity to human 
antigens and result in immune activation (Isogai et al., 1990).
In a study reported in this issue, Cho and co-workers sought to explore the 
target antigens in BD by studying a cohort of BD patients in conjunction with 
a variety of control patients. Using sera from patients with BD and molecular 
biologic techniques, these researchers identified a candidate 36- to 40-kDa 
antigen that was either detected at low levels or not detected at all in sera 
from healthy subjects or control patients with other diseases. Advanced liq-
uid chromatography approaches enabled the discovery of a peptide finger-
print of the protein, and a scanning algorithm from the National Center for Biotechnology Information identified 
this protein as the heterogeneous nuclear protein ribonucleoprotein (hnRNP)-A2/B1. Furthermore, anti-endothe-
lial cell IgA antibodies thought to target this antigen were found in serum samples from BD patients.
Given that some patients with BD have antibodies to streptococcal heat shock protein-65 (hsp-65), the inves-
tigators evaluated the cross-reactivity between serum IgA directed against recombinant hnRNP-A2/B1 and that 
directed against recombinant streptococcal hsp-65. A correlation was found between reactivity to hnRNP-A2/B1 
and hsp-65 in patients with BD. The question of how these antibodies lead to disease remains unanswered, and 
therefore further investigation is warranted. Through the following questions, we examine this paper in great-
er detail. For brief answers, please refer to the supplementary information online <http://www.nature.com/jid/
journal/v132/n3/suppinfo/jid20128s1.html>.
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QUESTIONS
1. What is Behçet’s disease?
2. How did the investigators carry out their study?
3. What were the results?
4. What were their conclusions and implications? 
for answers, visit our website or scan the adjacent tag.
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